PHK
PNT

Point72 Hong Kong’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Point72 Hong Kong’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-210
Closed -$1K – 2534
2022
Q2 		$1K Buy
+210
New +$1.61K ﹤0.01% 1838
2021
Q4 		– Sell
-8,241
Closed -$63K – 2528
2021
Q3 		$63K Buy
+8,241
New +$75.2K ﹤0.01% 1470
2021
Q2 		– Sell
-8,241
Closed -$87K – 2452
2021
Q1 		$87K Buy
+8,241
New +$112K ﹤0.01% 1183

Other funds holding PNT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Point72 Hong Kong's PNT Position: Q3 2022 in Review

Point72 Hong Kong sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2022, closing a stake of 210 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in PNT in Q1 2021 and held it in 3 quarters. The position peaked at $87K in Q1 2021. 106 funds tracked by Wall St. Rank hold PNT as of Q3 2022.

  • Point72 Hong Kong reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 210 POINT Biopharma Global Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Point72 Hong Kong's POINT Biopharma Global Inc. Common Stock position peaked at $87K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.